Skip to main content

Table 1 Demographic of 103 nr-axSpA subjects with chronic inflammatory back pain and morning stiffness

From: MRI contributes to accurate and early diagnosis of non-radiographic HLA-B27 negative axial spondyloarthritis

 

Age (yr)

Gender male (%)

BASDAI

ASDAS-CRP

ASDAS-ESR

Abnormal serum CRP (%)

Abnormal serum ESR (%)

SPARCC scores

Structural damage of MRI-SIJs

Sclerosis

Erosion

fJSW

DPa

TPb

Group 1 (n = 36)

31.3 ± 11.99

75%

2.47  ±  1.50

2.19  ±  0.66

1.90  ±  0.81

30.6%

33.3%

6.73 ± 7.73

77.8%

97.2%

44.4%

33.3%

30.6%

Group 2 (n = 22)

31.59 ± 12.51

86.4%

1.98  ±   0.82

1.86  ±  0.85

1.60  ±   0.60

22.7%

18.2%

NA

40.9%

100%

13.6%

27.3%

13.6%

Group 3 (n = 45)

30.09 ± 13.78

66.7%

2.36  ±  0.89

2.03  ±  0.59

1.73   ±   0.59

20%

24.4%

NA

51.1%

93.3%

8.9%

37.8%

8.9%

Group 1 + 2c (n = 58)

31.41 ± 12.08

79.3%

2.28  ±   1.27

2.06  ±  0.75

1.79  ±   0.75

27.6%

27.6%

4.83 ± 6.85

63.8%

98.3%

32.8%

32.8%

31.0%

Group 1 + 2 + 3 (n = 103)

32.15 ± 12.81

73.8%

2.32  ±  1.12

2.05  ±  0.68

1.76  ±   0.68

24.3%

26.2%

2.49 ± 5.46

58.3%

96.1%

22.3%

35.0%

21.4%

  1. BASDAI Bath Ankylosing Spondylitis Disease Activity Index, ASDAS Ankylosing Spondylitis Disease Activity Scores, CRP C-reactive protein, ESR erythrocyte sedimentation rate, BME bone marrow edema, MRI magnetic resonance imaging, SIJ sacroiliac joint, SPARCC Spondyloarthritis Research Consortium of Canada, fJSW focal joint space widening, ASAS Assessment of Spondyloarthritis international Society, nr-axSpA nonradiographic spondyloarthritis; Group 1, (MRI( +)/ mNY(−)); Group 2, [MRI(−)/ mNY(−)/ HLA-B27( +)]; Group 3, [MRI(−)/ mNY(-)/ HLA-B27(−)]; NA not applicable; aDP, double positive, dual presence of sclerosis and erosion on SIJ MRI; bTP, triple positive, simultaneous presence of sclerosis, erosion, and fJSW on MRI-SIJs; cgroup 1 + 2, ASAS defined nr-axSpA